INNV

Business Context and Reporting Period

Company: InnovAge Holding Corp. (INNV)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended March 31, 2026
Business Overview: InnovAge is the largest PACE (Program of All-Inclusive Care for the Elderly) provider in the U.S., serving approximately 8,050 frail, dual-eligible seniors across 20 centers in six states. The company operates on a fully capitated model, assuming 100% financial risk for participant healthcare costs.

Key Financial Metrics

Liquidity: As of March 31, 2026, the company held $95.5 million in cash and cash equivalents and $43.1 million in short-term investments. The Revolving Credit Facility has $84.4 million of remaining capacity.

Material Changes vs. Prior Period

• Revenue Growth: Total revenues increased 15.5% year-over-year for the quarter and 15.1% for the nine-month period, driven by a 6.7% increase in member months and higher capitation rates (7.8% Medicaid increase, 5.0% Medicare increase).
• GAAP Net Loss Improvement: The nine-month net loss narrowed significantly to $10.5 million from $30.3 million in the prior year, primarily due to the absence of $8.5 million in impairment charges related to a halted de novo center in Kentucky recorded in the prior period.
• Expense Volatility: Corporate, general, and administrative (G&A) expenses surged 98.3% for the quarter and 41.6% for the nine months. This was largely driven by a $35.5 million net increase in litigation accruals, including a $16.3 million settlement with former pharmacy vendor Grane Rx.
• Operating Cash Flow: Net cash provided by operating activities increased to $43.4 million for the nine months ended March 31, 2026, compared to $23.9 million in the prior year.

Guidance, Outlook, Risks, and Unusual Items

Management Commentary and Outlook

Management expects continued growth in census and capitation rates but anticipates margin pressure in fiscal 2027 due to potential Medicaid rate reductions and the impact of the "One Big Beautiful Bill Act" (OBBBA). The company is executing clinical and operational value initiatives to offset rising care costs.

Key Risks and Contingencies

• Regulatory Actions: The California Department of Health Care Services (DHCS) has paused PACE applications for a minimum of two years, impacting new center openings in the state, though Downey and Bakersfield applications remain under review. DHCS also issued a Corrective Action Plan regarding the San Bernardino center.
• Litigation: The company has accrued approximately $34.4 million for litigation matters as of March 31, 2026. This includes ongoing discussions with the DOJ regarding civil investigative demands and a settled stockholder lawsuit.
• Medicaid Funding: The OBBBA may constrain state provider taxes and lead to reduced Medicaid spending, potentially affecting reimbursement rates and workforce availability.

Unusual Items

The significant increase in G&A expenses is non-recurring in nature, driven by specific legal settlements and accruals. The company also recorded a $0.1 million loss on the sale of its Senior Housing assets, which were divested in September 2025.

Investor Verification Checklist

• Litigation Accruals: Verify the sufficiency of the $34.4 million litigation accrual and the potential for additional exposure from DOJ investigations.
• California Expansion: Monitor the status of the DHCS moratorium and the Corrective Action Plan for the San Bernardino center, as these directly impact growth in the company's largest market.
• Medicaid Rate Trends: Assess the impact of the OBBBA on future Medicaid capitation rates, particularly in Colorado and California, which could compress margins in fiscal 2027.
• Debt Covenants: Confirm continued compliance with the Credit Agreement covenants, specifically the secured net leverage ratio, given the recent debt refinancing.
• Non-GAAP Reconciliations: Review the reconciliation of Adjusted EBITDA to ensure the exclusion of litigation costs and settlements aligns with management's definition of "core" performance.